AAAAAA
Results: 1-25/391
Authors:
SAIVIN S
HULOT T
CHABAC S
POTGIETER A
DURBIN P
HOUIN G
Citation: S. Saivin et al., CLINICAL PHARMACOKINETICS OF ACAMPROSATE, Clinical pharmacokinetics, 35(5), 1998, pp. 331-345
Authors:
NICOLAS P
TOD M
PADOIN C
PETITJEAN O
Citation: P. Nicolas et al., CLINICAL PHARMACOKINETICS OF DIACEREIN, Clinical pharmacokinetics, 35(5), 1998, pp. 347-359
Authors:
LIN JH
LU AYH
Citation: Jh. Lin et Ayh. Lu, INHIBITION AND INDUCTION OF CYTOCHROME-P450 AND THE CLINICAL IMPLICATIONS, Clinical pharmacokinetics, 35(5), 1998, pp. 361-390
Authors:
HEINIG R
Citation: R. Heinig, CLINCIAL PHARMACOKINETICS OF NISOLDIPINE COAT-CORE (VOL 35, PG 191, 1998), Clinical pharmacokinetics, 35(5), 1998, pp. 390-390
Authors:
MACGOWAN AP
BOWKER KE
Citation: Ap. Macgowan et Ke. Bowker, CONTINUOUS-INFUSION OF BETA-LACTAM ANTIBIOTICS, Clinical pharmacokinetics, 35(5), 1998, pp. 391-402
Authors:
BERNAREGGI A
Citation: A. Bernareggi, CLINICAL PHARMACOKINETICS OF NIMESULIDE, Clinical pharmacokinetics, 35(4), 1998, pp. 247-274
Authors:
HSU A
GRANNEMAN GR
BERTZ RJ
Citation: A. Hsu et al., RITONAVIR - CLINICAL PHARMACOKINETICS AND INTERACTIONS WITH OTHER ANTI-HIV AGENTS, Clinical pharmacokinetics, 35(4), 1998, pp. 275-291
Authors:
KENNEDY JM
VANRIJI AM
Citation: Jm. Kennedy et Am. Vanriji, EFFECTS OF SURGERY ON THE PHARMACOKINETIC PARAMETERS OF DRUGS, Clinical pharmacokinetics, 35(4), 1998, pp. 293-312
Authors:
REY E
TRELUYER JM
PONS G
Citation: E. Rey et al., DRUG DISPOSITION IN CYSTIC-FIBROSIS, Clinical pharmacokinetics, 35(4), 1998, pp. 313-329
Authors:
HONIG PK
GILLESPIE BK
Citation: Pk. Honig et Bk. Gillespie, CLINICAL-SIGNIFICANCE OF PHARMACOKINETIC DRUG-INTERACTIONS WITH OVER-THE-COUNTER (OTC) DRUGS, Clinical pharmacokinetics, 35(3), 1998, pp. 167-171
Authors:
GOURLAY GK
Citation: Gk. Gourlay, SUSTAINED RELIEF OF CHRONIC PAIN - PHARMACOKINETICS OF SUSTAINED-RELEASE MORPHINE, Clinical pharmacokinetics, 35(3), 1998, pp. 173-190
Authors:
HEINIG R
Citation: R. Heinig, CLINICAL PHARMACOKINETICS OF NISOLDIPINE COAT-CORE, Clinical pharmacokinetics, 35(3), 1998, pp. 191-208
Authors:
BOUCHER BA
HANES SD
Citation: Ba. Boucher et Sd. Hanes, PHARMACOKINETIC ALTERATIONS AFTER SEVERE HEAD-INJURY - CLINICAL RELEVANCE, Clinical pharmacokinetics, 35(3), 1998, pp. 209-221
Authors:
NAU R
SORGEL F
PRANGE HW
Citation: R. Nau et al., PHARMACOKINETIC OPTIMIZATION OF THE TREATMENT OF BACTERIAL CENTRAL-NERVOUS-SYSTEM INFECTIONS, Clinical pharmacokinetics, 35(3), 1998, pp. 223-246
Authors:
BRUGUEROLLE B
Citation: B. Bruguerolle, CHRONOPHARMACOKINETICS - CURRENT STATUS, Clinical pharmacokinetics, 35(2), 1998, pp. 83-94
Authors:
RUSSO H
BRESSOLLE F
Citation: H. Russo et F. Bressolle, PHARMACODYNAMICS AND PHARMACOKINETICS OF THIOPENTAL, Clinical pharmacokinetics, 35(2), 1998, pp. 95-134
Authors:
DALNEGRO R
Citation: R. Dalnegro, PHARMACOKINETIC DRUG-INTERACTIONS WITH ANTIULCER DRUGS, Clinical pharmacokinetics, 35(2), 1998, pp. 135-150
Authors:
BELLISSANT E
SEBILLE V
PAINTAUD G
Citation: E. Bellissant et al., METHODOLOGICAL ISSUES IN PHARMACOKINETIC-PHARMACODYNAMIC MODELING, Clinical pharmacokinetics, 35(2), 1998, pp. 151-166
Authors:
WADA DR
DROVER DR
LEMMENS HJM
Citation: Dr. Wada et al., DETERMINATION OF THE DISTRIBUTION VOLUME THAT CAN BE USED TO CALCULATE THE INTRAVENOUS LOADING DOSE, Clinical pharmacokinetics, 35(1), 1998, pp. 1-7
Authors:
KIRSTEN R
NELSON K
KIRSTEN D
HEINTZ B
Citation: R. Kirsten et al., CLINICAL PHARMACOKINETICS OF VASODILATORS - PART II, Clinical pharmacokinetics, 35(1), 1998, pp. 9-36
Authors:
BLUMER JL
Citation: Jl. Blumer, CLINICAL-PHARMACOLOGY OF MIDAZOLAM IN INFANTS AND CHILDREN, Clinical pharmacokinetics, 35(1), 1998, pp. 37-47
Authors:
HAMMERLEIN A
DERENDORF H
LOWENTHAL DT
Citation: A. Hammerlein et al., PHARMACOKINETIC AND PHARMACODYNAMIC CHANGES IN THE ELDERLY - CLINICALIMPLICATIONS, Clinical pharmacokinetics, 35(1), 1998, pp. 49-64
Authors:
WILLIAMS DN
RAYMOND JL
Citation: Dn. Williams et Jl. Raymond, COMMUNITY-BASED PARENTERAL ANTIINFECTIVE THERAPY (COPAT) - PHARMACOKINETIC AND MONITORING ISSUES, Clinical pharmacokinetics, 35(1), 1998, pp. 65-77
Authors:
SKJODT NM
DAVIES NM
Citation: Nm. Skjodt et Nm. Davies, CLINICAL PHARMACOKINETICS OF LORNOXICAM - A SHORT HALF-LIFE OXICAM, Clinical pharmacokinetics, 34(6), 1998, pp. 421-428
Authors:
BULLINGHAM RES
NICHOLLS AJ
KANMM BR
Citation: Res. Bullingham et al., CLINICAL PHARMACOKINETICS OF MYCOPHENOLATE MOFETIL, Clinical pharmacokinetics, 34(6), 1998, pp. 429-455